Jamie L. Reynoso - 07 Sep 2023 Form 4/A Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Signature
/s /Scott Leffler as attorney-in-fact for Jamie L. Reynoso
Issuer symbol
CLOV
Transactions as of
07 Sep 2023
Net transactions value
$0
Form type
4/A
Filing time
03 Jan 2024, 16:30:00 UTC
Date Of Original Report
11 Sep 2023
Previous filing
16 Jun 2023
Next filing
18 Sep 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLOV Class A Common Stock Award $0 +652,566 +47% $0.000000 2,033,451 07 Sep 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed solely to correct the number of restricted stock units (RSUs) received upon determination of the level of performance, as described in Footnote 2 below.
F2 Represents RSUs, each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on March 16, 2023. One-third of the number of earned RSUs vested and were settled on September 7, 2023, and one-third of the number of earned RSUs will vest on each of June 30, 2024, and June 30, 2025, subject to the Reporting Person's continued employment through each vesting date.

Remarks:

Ex-24 Power of Attorney